GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Shiller PE Ratio

Samjin Pharmaceutical Co (XKRX:005500) Shiller PE Ratio : (As of Sep. 21, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Samjin Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Samjin Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co Shiller PE Ratio Chart

Samjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.99 16.01 13.58 12.15 9.56

Samjin Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.84 9.82 9.56 9.12 -

Competitive Comparison of Samjin Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Samjin Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samjin Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samjin Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Samjin Pharmaceutical Co's Shiller PE Ratio falls into.



Samjin Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Samjin Pharmaceutical Co's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Samjin Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=1947/*
=

Current CPI (Jun. 2024) = .

Samjin Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 461.000 99.608 0.000
201412 203.000 99.098 0.000
201503 529.000 99.720 0.000
201506 575.000 100.050 0.000
201509 586.000 100.110 0.000
201512 482.000 100.220 0.000
201603 647.000 100.560 0.000
201606 668.000 100.790 0.000
201609 732.000 101.460 0.000
201612 376.000 101.560 0.000
201703 690.000 102.850 0.000
201706 781.000 102.610 0.000
201709 853.000 103.490 0.000
201712 568.000 102.990 0.000
201803 877.000 104.100 0.000
201806 956.000 104.130 0.000
201809 933.000 105.650 0.000
201812 -742.000 104.350 0.000
201903 932.000 104.490 0.000
201906 -906.000 104.880 0.000
201909 747.000 105.200 0.000
201912 193.000 105.120 0.000
202003 690.000 105.540 0.000
202006 653.000 104.870 0.000
202009 443.000 106.200 0.000
202012 480.000 105.765 0.000
202103 553.000 107.357 0.000
202106 668.000 107.579 0.000
202109 1,286.000 108.759 0.000
202112 -197.000 109.676 0.000
202203 295.000 111.806 0.000
202206 340.000 114.083 0.000
202209 337.000 114.831 0.000
202212 755.000 115.200 0.000
202303 662.000 116.550 0.000
202306 62.000 117.140 0.000
202309 246.000 119.111 0.000
202312 574.000 118.848 0.000
202403 243.000 118.848 0.000
202406 1,947.000 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Samjin Pharmaceutical Co  (XKRX:005500) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Samjin Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Samjin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co Headlines

No Headlines